The Chemours Company (CC)

The Chemours Company Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	1,807	1,304	1,551	1,105	943
Cash & Cash Equivalents	1,807	1,304	1,551	1,105	943
Cash Growth	38.57%	-15.93%	40.36%	17.18%	-21.48%
Receivables	610	626	720	511	674
Inventory	1,352	1,404	1,099	939	1,079
Other Current Assets	66	-120	-25	78	81
Total Current Assets	3,835	3,214	3,345	2,633	2,777
Property, Plant & Equipment	3,476	3,411	3,381	3,710	3,853
Long-Term Investments	158	175	169	167	162
Goodwill and Intangibles	105	115	108	167	174
Other Long-Term Assets	677	725	547	405	292
Total Long-Term Assets	4,416	4,426	4,205	4,449	4,481
Total Assets	8,251	7,640	7,550	7,082	7,258
Accounts Payable	1,159	1,233	1,162	844	923
Current Debt	51	43	25	21	134
Other Current Liabilities	1,276	615	671	577	484
Total Current Liabilities	2,486	1,891	1,858	1,442	1,541
Long-Term Debt	4,193	3,788	3,903	4,199	4,271
Other Long-Term Liabilities	833	854	707	626	751
Total Long-Term Liabilities	5,026	4,642	4,610	4,825	5,022
Total Liabilities	7,512	6,533	6,468	6,267	6,563
Total Debt	4,244	3,831	3,928	4,220	4,405
Debt Growth	10.78%	-2.47%	-6.92%	-4.20%	10.90%
Retained Earnings	1,782	2,170	1,746	1,303	1,249
Comprehensive Income	-274	-343	-364	-310	-349
Shareholders' Equity	737	1,107	1,081	813	689
Net Cash / Debt	-2,437	-2,527	-2,377	-3,115	-3,462
Working Capital	1,349	1,323	1,487	1,191	1,236
Book Value Per Share	4.96	7.33	6.63	4.94	4.21

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).